Why Don’t We Have Better Alzheimer’s Drugs Yet? | Jack Hidary at Davos 2026

After decades of research, we still don’t have breakthrough treatments for diseases like Alzheimer's disease.

We need AI trained on biology, chemistry, and physics: models that can simulate how drugs behave before they reach human trials.

That’s the promise of large quantitative models (LQMs).

Interview via Anastasios Economou (iGrow) https://www.igrow.vc

Learn more about SandboxAQ's quantitative AI here: https://www.sandboxaq.com/solutions/large-quantitative-models

#sandboxaq #lqms

Видео Why Don’t We Have Better Alzheimer’s Drugs Yet? | Jack Hidary at Davos 2026 канала SandboxAQ